223 related articles for article (PubMed ID: 15025561)
1. Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene.
Johnston LA; Erdogan S; Cheung YF; Sullivan M; Barber R; Lynch MJ; Baillie GS; Van Heeke G; Adams DR; Huston E; Houslay MD
Biochem J; 2004 Jun; 380(Pt 2):371-84. PubMed ID: 15025561
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene.
Wallace DA; Johnston LA; Huston E; MacMaster D; Houslay TM; Cheung YF; Campbell L; Millen JE; Smith RA; Gall I; Knowles RG; Sullivan M; Houslay MD
Mol Pharmacol; 2005 Jun; 67(6):1920-34. PubMed ID: 15738310
[TBL] [Abstract][Full Text] [Related]
3. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2.
Bolger GB; Peden AH; Steele MR; MacKenzie C; McEwan DG; Wallace DA; Huston E; Baillie GS; Houslay MD
J Biol Chem; 2003 Aug; 278(35):33351-63. PubMed ID: 12810716
[TBL] [Abstract][Full Text] [Related]
5. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
[TBL] [Abstract][Full Text] [Related]
6. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
[TBL] [Abstract][Full Text] [Related]
7. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
[TBL] [Abstract][Full Text] [Related]
8. In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting.
Beard MB; Huston E; Campbell L; Gall I; McPhee I; Yarwood S; Scotland G; Houslay MD
Cell Signal; 2002 May; 14(5):453-65. PubMed ID: 11882390
[TBL] [Abstract][Full Text] [Related]
9. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
10. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.
Sullivan M; Rena G; Begg F; Gordon L; Olsen AS; Houslay MD
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):693-703. PubMed ID: 9677330
[TBL] [Abstract][Full Text] [Related]
12. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246
[TBL] [Abstract][Full Text] [Related]
13. The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases.
Richter W; Conti M
J Biol Chem; 2004 Jul; 279(29):30338-48. PubMed ID: 15131123
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
[TBL] [Abstract][Full Text] [Related]
15. Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum.
Shakur Y; Takeda K; Kenan Y; Yu ZX; Rena G; Brandt D; Houslay MD; Degerman E; Ferrans VJ; Manganiello VC
J Biol Chem; 2000 Dec; 275(49):38749-61. PubMed ID: 10952971
[TBL] [Abstract][Full Text] [Related]
16. In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
McCahill A; McSorley T; Huston E; Hill EV; Lynch MJ; Gall I; Keryer G; Lygren B; Tasken K; van Heeke G; Houslay MD
Cell Signal; 2005 Sep; 17(9):1158-73. PubMed ID: 15905070
[TBL] [Abstract][Full Text] [Related]
17. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
18. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
[TBL] [Abstract][Full Text] [Related]
19. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution.
Huston E; Beard M; McCallum F; Pyne NJ; Vandenabeele P; Scotland G; Houslay MD
J Biol Chem; 2000 Sep; 275(36):28063-74. PubMed ID: 10829034
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform.
Shepherd M; McSorley T; Olsen AE; Johnston LA; Thomson NC; Baillie GS; Houslay MD; Bolger GB
Biochem J; 2003 Mar; 370(Pt 2):429-38. PubMed ID: 12441002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
